中国神经再生研究(英文版)

中国神经再生研究(英文版) ›› 2012, Vol. 7 ›› Issue (29): 2313-2319.

• 原著:脑损伤修复保护与再生 • 上一篇    

XRCC1 Arg399Gln多态性可以显著提高亚洲人神经胶质瘤发病风险：meta分析

  

  • 收稿日期:2012-06-18 修回日期:2012-08-07 出版日期:2012-10-15 发布日期:2012-10-15

X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians A meta-analysis based on 2 326 cases and 3 610 controls

Liang Zhang, Zhiqun Qiu, Jiaohua Luo, Weiqun Shu   

  1. Department of Environmental Hygiene, College of Preventive Medicine, Third Military Medical University of Chinese PLA, Chongqing 400037, China
  • Received:2012-06-18 Revised:2012-08-07 Online:2012-10-15 Published:2012-10-15
  • Contact: Weiqun Shu, Professor, Department of Environmental Hygiene, College of Preven-tive Medicine, Third Military Medical University of Chi-nese PLA, Chongqing 400037, China sydswq@163.com
  • About author:Liang Zhang★, Master, Experimentalist, Department of Environmental Hygiene, College of Preventive Medi-cine, Third Military Medical University of Chinese PLA, Chongqing 400037, China

PDF

1000

Abstract:

OBJECTIVE: Previous reports have demonstrated that X-ray repair cross-complementing gene 1 (XRCC1) Arg399Gln polymorphism is a possible risk factor for several cancers. Published data on the association of XRCC1 Arg399Gln polymorphism with glioma susceptibility have generated conflicting results. This study is designed to precisely estimate the relationship.
DATA RETRIEVAL: A computer-based online retrieval of Medline, EMBASE, OVID, Sciencedirect, and Chinese National Knowledge Infrastructure was performed to search papers regarding association of XRCC1 Arg399Gln polymorphisms with glioma published up to April 2012.
SELECTION CRITERIA: Two investigators selected data independently. Meta analysis was then performed for the selected studies using STATA 11.0 software after strict selection. Heterogeneity test, sensitivity analysis and publication bias assessments were then conducted.
MAIN OUTCOME MEASURES: Association of XRCC1 Arg399Gln polymorphism with glioma risk.
RESULTS: A total of nine case-controlled studies comprising 2 326 cases and 3 610 controls were selected for final analysis. The overall data failed to indicate a significant association of XRCC1 Arg399Gln polymorphism with glioma risk (Gln/Gln vs. Arg/Arg: odds ratio (OR) = 1.11; 95% confidence interval (CI) = 0.94–1.31; dominant model: OR = 1.06; 95%CI = 0.95–1.18; recessive model: OR = 1.04; 95%CI = 0.81–1.34). However, subgroup analysis regarding ethnicity showed an increased risk among Asians (Gln/Gln vs. Arg/Arg: OR = 1.70; 95%CI = 1.17–2.46; dominant model: OR = 1.40; 95%CI = 1.10–1.78; recessive model: OR = 1.46; 95%CI = 1.04–2.05) but not Caucasians or mixed ethnicities.
CONCLUSION: XRCC1 Arg399Gln polymorphism might modify the susceptibility to glioma among Asians but not Caucasians. Further large and well-designed studies are needed to confirm this conclusion.

Key words: genetic association, XRCC1 Arg399Gln, glioma, malignancy, susceptibility, meta analysis, polymorphism, risk, case-controlled study, database, variation